Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
Dal Sasso, Nielsen: «Nel secondo semestre possibile chiusura in pareggio per il mercato» | Engage
04:05pm, Monday, 25'th May 2020
Secondo Dal Sasso di Nielsen, questo porterebbe il settore a chiudere il 2020 in calo a doppia cifra, in vista di un 2021 sicuramente più "effervescente"
Nielsen: pubblicità a -9,2% tra gennaio e marzo. La ripresa? Sarà nel secondo semestre | Engage
02:23pm, Monday, 25'th May 2020
Il Covid-19 ha portato il mercato pubblicitario a chiudere marzo a -29% secondo Nielsen. Ma ha anche stimolato un profondo cambiamento nella comunicazione
Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
12:30pm, Thursday, 21'st May 2020
Ultragenyx Pharmaceutical, Inc. (RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases and Arcturus The
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Coronavirus: Ever-changing profile of a silent killer with many questions left unanswered
09:00pm, Wednesday, 13'th May 2020
Why is this virus so much more contagious than Sars? Why do some patients develop a severe form of the disease while others do not?. Read more at straitstimes.com.
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now?
12:53pm, Tuesday, 12'th May 2020
Arcturus Therapeutics (ARCT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
Eli Lilly's Retevmo, And Other News: The Good, Bad And Ugly Of Biopharma
02:48pm, Monday, 11'th May 2020
Eli Lilly's Retevmo gets FDA approval. Arcturus announces positive preclinical data for Covid-19. Quidel's antigen test kit gets FDA approval.
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Call Transcript
10:30am, Sunday, 10'th May 2020
Image source: The Motley Fool. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)Q1 2020 Earnings CallMay 07, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants
Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)
01:30pm, Friday, 08'th May 2020
New data provides evidence of adaptive cellular (CD8+ cells) and balanced (Th1/Th2) immune responses STARR™ mRNA elicits anti-spike protein antibodies (IgG), higher than.
Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update
08:01pm, Thursday, 07'th May 2020
Important progress advancing COVID-19 STARR™ mRNA vaccine candidate (LUNAR-COV19);New preclinical data demonstrate robust immunogenicity with a single, low dose Company remains.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
